HK16090A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
HK16090A
HK16090A HK160/90A HK16090A HK16090A HK 16090 A HK16090 A HK 16090A HK 160/90 A HK160/90 A HK 160/90A HK 16090 A HK16090 A HK 16090A HK 16090 A HK16090 A HK 16090A
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
HK160/90A
Other languages
English (en)
Inventor
Robert Charles Hider
George Kontoghiorghes
Michael Arthur Stockham
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA000524044A external-priority patent/CA1338496C/en
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of HK16090A publication Critical patent/HK16090A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
HK160/90A 1982-10-22 1990-03-01 Pharmaceutical compositions HK16090A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8230150 1982-10-22
CA000446932A CA1243606A (en) 1982-10-22 1984-02-07 Pharmaceutical compositions containing iron complexes of 3-hydroxy-4-pyrones
CA000524044A CA1338496C (en) 1982-10-22 1986-11-28 Pharmaceutically active iron complexes of 3-hydroxy-4-pyrones

Publications (1)

Publication Number Publication Date
HK16090A true HK16090A (en) 1990-03-09

Family

ID=27167414

Family Applications (1)

Application Number Title Priority Date Filing Date
HK160/90A HK16090A (en) 1982-10-22 1990-03-01 Pharmaceutical compositions

Country Status (8)

Country Link
US (3) US4575502A (nl)
EP (1) EP0107458B1 (nl)
JP (2) JPS5993071A (nl)
AU (1) AU567915B2 (nl)
CA (1) CA1243606A (nl)
DK (1) DK485383D0 (nl)
GB (1) GB2128998B (nl)
HK (1) HK16090A (nl)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2128998B (en) * 1982-10-22 1986-07-16 Nat Res Dev Pharmaceutical compositions of iron complexes of 3 hydroxy-4-pyrone
USRE37534E1 (en) 1982-10-22 2002-01-29 Btg International Limited Pharmaceutical compositions
US4708862A (en) * 1983-02-22 1987-11-24 Xoma Corporation Radioimmuno detection of human cancers using anti-tumor monoclonal antibody
US4912118A (en) * 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
GB8410290D0 (en) * 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
US5177068A (en) * 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
GB8410289D0 (en) * 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
GB8615041D0 (en) * 1986-06-20 1986-07-23 Silver J Pharmaceutical compositions
US6004951A (en) * 1989-11-22 1999-12-21 Bernstein; Lawrence Richard Administration of gallium complexes of 3-hydroxy-4-pyrones to provide physiologically active gallium levels in a mammalian individual
US5258376A (en) * 1989-11-22 1993-11-02 Bernstein Lawrence R Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
US5574027A (en) * 1989-11-22 1996-11-12 Bernstein; Lawrence R. Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
GB9006522D0 (en) * 1990-03-23 1990-05-23 Hider Robert C Metal complexes
AU7981791A (en) * 1990-05-24 1991-12-10 Fujisawa, Inc. Orally administrable gallium compositions and methods of treatment therewith
US5298525A (en) * 1992-11-23 1994-03-29 University Technologies International, Inc. Diabetes prevention and treatment
ES2230564T3 (es) 1995-06-10 2005-05-01 Vitra Pharmaceuticals Ltd. Compuestos ferricos, composiciones, metodos de fabricacion de estos y sus utilizacioneds.
US5906978A (en) * 1996-08-14 1999-05-25 Hemocleanse, Inc. Method for iron delivery to a patient by transfer from dialysate
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method
DE69924265T2 (de) * 1998-09-23 2005-08-25 Unilever N.V. Mundpflegemittel
PT1072198E (pt) * 1999-07-28 2008-06-17 Swiss Caps Rechte & Lizenzen Preparado, especialmente para utilização como medicamento e/ou como suplemento alimentar
US6767741B1 (en) 1999-08-27 2004-07-27 Invitrogen Corporation Metal binding compounds and their use in cell culture medium compositions
AU2001287850A1 (en) 2000-09-19 2002-04-02 Vitra Pharmaceuticals Limited Iron compositions
US7073271B2 (en) * 2002-02-14 2006-07-11 Faro Technologies Inc. Portable coordinate measurement machine
RU2209062C1 (ru) * 2002-03-19 2003-07-27 Институт физиологии им. И.П.Павлова РАН Вещество, обладающее седативным действием
GB0211500D0 (en) * 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
AU2005284909B2 (en) * 2004-09-13 2011-11-17 Gilead Sciences, Inc. Delivering iron to an animal
RU2007117147A (ru) * 2004-10-08 2008-11-20 Юнилевер Н.В. (Nl) Комплекс железа
US7857977B2 (en) * 2005-07-12 2010-12-28 Rockwell Medical Technologies, Inc. Packaging of ferric pyrophosphate for dialysis
US7816404B2 (en) 2007-07-20 2010-10-19 Rockwell Medical Technologies, Inc. Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions
GB0808835D0 (en) * 2008-05-15 2008-06-18 Vitra Pharmaceuticals Ltd Therapeutic compositions
MX2011013679A (es) 2009-06-16 2012-01-20 Schering Corp Esteroides de heteroarilo [3.2-c] novedosos como agonistas de receptor de glucocorticoide composiciones y uso de los mismos.
WO2011117225A1 (de) 2010-03-23 2011-09-29 Vifor (International) Ag Fe(iii)-komplexverbindungen zur behandlung und prophylaxe von eisenmangelerscheinungen und eisenmangelanämien
GB201101370D0 (en) 2011-01-27 2011-03-09 Iron Therapeutics Holdings Ag Process
MY168952A (en) 2011-03-29 2019-01-28 Vifor Int Ag Fe (iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
AR086606A1 (es) 2011-05-31 2014-01-08 Vifor Int Ag Compuestos del complejo de fe(iii) para el tratamiento y profilaxis de los sintomas de la deficiencia de hierro y las anemias por deficiencia de hierro
CN105246473B (zh) 2012-12-21 2018-07-13 维福（国际）股份有限公司 用于缺铁症状和缺铁性贫血的治疗和预防的Fe(III)络合化合物
GB201404390D0 (en) * 2014-03-12 2014-04-23 Iron Therapeutics Holdings Ag Composition
GB2531742B (en) * 2014-10-28 2016-10-05 Iron Therapeutics Holdings Ag Polymorphs of ferric maltol
IT202100018578A1 (it) * 2021-07-14 2023-01-14 Indena Spa Dispersione amorfa di maltolo ferrico e relativo processo di preparazione
US11661819B2 (en) 2021-08-03 2023-05-30 Baker Hughes Oilfield Operations Llc Valve, method and system

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2904573A (en) * 1957-05-06 1959-09-15 Ortho Pharma Corp Ferrous citrate complex
US2865938A (en) * 1957-09-25 1958-12-23 Hyman Rosenstein Iron choline compound and production thereof
US3130204A (en) * 1962-02-07 1964-04-21 Pfizer & Co C Preparation of gamma-pyrones
FR2130M (fr) * 1962-04-25 1963-11-12 Rech S Appliquees Soc D Expl Médicament a base d'une solution aqueuse stable de chlorure ferreux et d'acide ascorbique.
DE1518098A1 (de) * 1963-09-19 1969-04-10 Pfizer & Co C Verfahren zur Herstellung von Pyromekonsaeurederivaten
US3821192A (en) * 1971-08-18 1974-06-28 Central Pharmacal Co Process for preparing an iron-saccharide complex
US4018937A (en) * 1972-12-14 1977-04-19 Rca Corporation Electron beam recording comprising polymer of 1-methylvinyl methyl ketone
US4058621A (en) * 1975-02-24 1977-11-15 Peter, Strong & Company, Inc. Iron complexes and foodstuffs containing them
DE2613500A1 (de) * 1975-04-01 1976-10-21 Procter & Gamble Mundpflegemittel und verfahren zur verhinderung von verfaerbungen der zaehne
US4018934A (en) * 1975-08-25 1977-04-19 General Foods Corporation Stabilization of iron - complex colors
US4018907A (en) * 1975-08-25 1977-04-19 General Foods Corporation Coloring food with iron-complexes
US4311691A (en) * 1979-10-09 1982-01-19 Fichera Anthony T Tobacco smoking inhibitor
GB2128998B (en) * 1982-10-22 1986-07-16 Nat Res Dev Pharmaceutical compositions of iron complexes of 3 hydroxy-4-pyrone

Also Published As

Publication number Publication date
EP0107458A1 (en) 1984-05-02
GB2128998B (en) 1986-07-16
DK485383D0 (da) 1983-10-21
US4834983A (en) 1989-05-30
JPH0545589B2 (nl) 1993-07-09
GB8327612D0 (en) 1983-11-16
CA1243606A (en) 1988-10-25
JPH0336807B1 (nl) 1991-06-03
JPS5993071A (ja) 1984-05-29
US4861767A (en) 1989-08-29
AU2455284A (en) 1985-08-15
AU567915B2 (en) 1987-12-10
US4575502A (en) 1986-03-11
JPH03223274A (ja) 1991-10-02
GB2128998A (en) 1984-05-10
EP0107458B1 (en) 1987-07-29

Similar Documents

Publication Publication Date Title
GB8326565D0 (en) Pharmaceutical compositions
HK16090A (en) Pharmaceutical compositions
GB2136807B (en) Pharmaceutical compositions
DE3467703D1 (en) Pharmaceutical compositions
CY1678A (en) Pharmaceutical compositions
ZA834074B (en) Pharmaceutical composition
GB2136806B (en) Pharmaceutical compositions
ZA833781B (en) Pharmaceutical compositions
EP0093551A3 (en) Pharmaceutical composition
CY1503A (en) Pharmaceutical compositions
GB2118176B (en) Pharmaceutical compositions
GB2117766B (en) Pharmaceutical compositions
PT77323A (en) Pharmaceutical compositions
GB8429749D0 (en) Pharmaceutical compositions
GB8313814D0 (en) Pharmaceutical compositions
GB8329700D0 (en) Anti-haemophilic pharmaceutical composition
DE3377696D1 (en) Pharmaceutical compositions
US4594359B1 (en) Pharmaceutical compositions
GB8328896D0 (en) Pharmaceutical composition
EP0136006A3 (en) Pharmaceutical compositions
GB2114001B (en) Nasel pharmaceutical compositions
GB8305028D0 (en) Pharmaceutical compositions
GB8314736D0 (en) Pharmaceutical compositions
GB8330810D0 (en) Pharmaceutical compositions
GB8332653D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)